LETTER TO THE EDITOR
New-onset diabetes in “long COVID”
Thirunavukkarasu Sathish,
Mary Chandrika Anton,
Tharsan Sivakumar,
Corresponding Author
Thirunavukkarasu Sathish
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
Correspondence
Thirunavukkarasu Sathish, Investigator, Population Health Research Institute, McMaster University, Hamilton, ON L8L 2X2, Canada.
Email: [email protected]
Search for more papers by this authorMary Chandrika Anton
Department of Biochemistry, Sree Balaji Medical College and Hospital, Chennai, India
Search for more papers by this authorTharsan Sivakumar
The Institute of Diabetes & Endocrinology, Scarborough, Ontario, Canada
Search for more papers by this authorThirunavukkarasu Sathish,
Mary Chandrika Anton,
Tharsan Sivakumar,
Corresponding Author
Thirunavukkarasu Sathish
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
Correspondence
Thirunavukkarasu Sathish, Investigator, Population Health Research Institute, McMaster University, Hamilton, ON L8L 2X2, Canada.
Email: [email protected]
Search for more papers by this authorMary Chandrika Anton
Department of Biochemistry, Sree Balaji Medical College and Hospital, Chennai, India
Search for more papers by this authorTharsan Sivakumar
The Institute of Diabetes & Endocrinology, Scarborough, Ontario, Canada
Search for more papers by this authorNo abstract is available for this article.
REFERENCES
- 1Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020; 8(6): 546-550.
- 2Rubino F, Amiel SA, Zimmet P, et al. New-onset diabetes in Covid-19. N Engl J Med. 2020; 383(8): 789-790.
- 3Sathish T, Cao Y. Is newly diagnosed diabetes as frequent as preexisting diabetes in COVID-19 patients? Diabetes Metab Syndr. 2021; 15(1): 147-148.
- 4Sathish T, Cao Y, Kapoor N. Newly diagnosed diabetes in COVID-19 patients. Prim Care Diabetes. 2021; 15(1): 194.
- 5Sathish T, Chandrika AM. Newly diagnosed diabetes in patients with mild to moderate COVID-19. Diabetes Metab Syndr. 2021; 15(2): 569-571.
- 6Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab. 2021; 23(3): 870-874.
- 7Sathish T, Cao Y. What is the role of admission HbA1c in managing COVID-19 patients? J Diabetes. 2021; 13(3): 273-275.
- 8Hollstein T, Schulte DM, Schulz J, et al. Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report. Nat Metab. 2020; 2(10): 1021-1024.
- 9Marchand L, Pecquet M, Luyton C. Type 1 diabetes onset triggered by COVID-19. Acta Diabetol. 2020; 57(10): 1265-1266.
- 10Beliard K, Wilkes M, Yau M, Aluf A, Rapaport R. SARS-CoV-2 infection-related diabetes mellitus. J Diabetes. 2021. https://doi.org/10.1111/1753-0407.13173.
- 11Xiang Y, Chau CK-L, Qiu J, Rao S, So H-C. Exploring causal relationships between COVID-19 and cardiometabolic disorders: a bi-directional Mendelian randomization study. medRxiv. 2021: March 20, 2021.21254008.
- 12Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021; 27(4): 601-615.
- 13 The Lancet. Facing up to long COVID. Lancet. 2020; 396(10266): 1861-1861.
- 14Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021; 372: n693.
- 15Daugherty SE, Guo Y, Heath K, et al. SARS-CoV-2 infection and risk of clinical sequelae during the post-acute phase: a retrospective cohort study. medRxiv. 2021: March 12, 2021.21253448.
- 16Yang L, Han Y, Nilsson-Payant BE, et al. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell. 2020; 27(1): 125-136.e7.
- 17Sathish T, Tapp RJ, Cooper ME, Zimmet P. Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes Metab. 2021; 47(2):101204.
- 18Lim S, Bae JH, Kwon H-S, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021; 17(1): 11-30.
- 19Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9(th) edition. Diabetes Res Clin Pract. 2019; 157: 107843.
- 20Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care Med. 2013; 41(6): e93-e94.
- 21Suh S, Park MK. Glucocorticoid-induced diabetes mellitus: an important but overlooked problem. Endocrinol Metab (Seoul). 2017; 32(2): 180-189.
- 22Lönnrot M, Lynch KF, Elding Larsson H, et al. Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study. Diabetologia. 2017; 60(10): 1931-1940.
- 23Mahase E. Covid-19: what do we know about "long covid"? BMJ. 2020; 370: m2815.
- 24 American Heart Association. COVID-19 CVD Registry. https://www.heart.org/en/professional/quality-improvement/covid-19-cvd-registry. Accessed April 15, 2021.
Citing Literature
